KA

Kineta, Inc.

1.30 USD
-0.99 (-43.23%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kineta, Inc. stock is down -50.19% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 12.5% of the previous 8 February’s closed higher than January.

About Kineta, Inc.

Yumanity Therapeutics Inc. engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. Its lead program is YTX-7739, a novel small molecule that is in Phase I clinical trial for the treatment of Parkinson's disease and related disorders of a-synuclein.